4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed 2021-08-13 Acc 0001209191-21-051438

Director bought 714 shares at an average $3.32 ($2,368)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
Jones James Director	2021-07-08	Purchase	+42	$3.18	$134	14,742	D
Jones James Director	2021-07-09	Purchase	+42	$3.13	$131	14,784	D
Jones James Director	2021-07-12	Purchase	+42	$3.33	$140	14,826	D
Jones James Director	2021-07-13	Purchase	+42	$3.48	$146	14,868	D
Jones James Director	2021-07-14	Purchase	+42	$3.33	$140	14,910	D
Jones James Director	2021-07-15	Purchase	+42	$3.27	$137	14,952	D
Jones James Director	2021-07-16	Purchase	+42	$3.28	$138	14,994	D
Jones James Director	2021-07-19	Purchase	+42	$3.23	$136	15,036	D
Jones James Director	2021-07-20	Purchase	+42	$3.24	$136	15,078	D
Jones James Director	2021-07-21	Purchase	+42	$3.26	$137	15,120	D
Jones James Director	2021-07-22	Purchase	+42	$3.36	$141	15,162	D
Jones James Director	2021-07-23	Purchase	+42	$3.35	$141	15,204	D
Jones James Director	2021-07-26	Purchase	+42	$3.39	$142	15,246	D
Jones James Director	2021-07-27	Purchase	+42	$3.39	$142	15,288	D
Jones James Director	2021-07-28	Purchase	+42	$3.42	$144	15,330	D
Jones James Director	2021-07-29	Purchase	+42	$3.42	$144	15,372	D
Jones James Director	2021-07-30	Purchase	+42	$3.31	$139	15,414	D
Open-market purchases · 714 sh · avg $3.32 · $2,368